West Pharmaceutical Services reported $213.3M in EBITDA for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Align Technology ALGN:US $ 264.47M 30.32M
Atrion ATRI:US 12.8M 117K
Avanos Medical Inc AVNS:US $ 21.2M 2.1M
Baxter International BAX:US $ 822M 124M
Becton, Dickinson and BDX:US $ 1368M 274M
Catalent CTLT:US $ 222M 104.3M
Cerus CERS:US $ -10.36M 3.26M
Charles River Laboratories CRL:US $ 226.29M 16.62M
Cooper Companies COO:US $ 164.7M 16M
Dentsply International XRAY:US 250M 0
Haemonetics HAE:US $ 55.92M 5.36M
Insulet PODD:US $ 48.2M 6.7M
Integra Lifesciences IART:US $ 104.32M 3.32M
IQVIA Holdings Inc IQV:US $ 662M 29M
Johnson & Johnson JNJ:US $ 8192M 2043M
Medtronic MDT:US $ 2283M 268M
Merit Medical Systems MMSI:US $ 44.96M 10.77M
Neogen NEOG:US $ 18.3M 9.13M
Quidel QDEL:US $ 294.63M 255.81M
Repligen RGEN:US $ 59.7M 2.24M
Sientra SIEN:US $ -10.66M 2.22M
Staar Surgical STAA:US $ 8.76M 2.78M
West Pharmaceutical Services WST:US $ 213.3M 25.4M